Literature DB >> 31767788

The effect of flavoured and non-flavoured tobacco on subjective experience, topography and toxicant exposure among waterpipe smokers.

Ziyad Ben Taleb1, Mayra Vargas2, Mohammad Ebrahimi Kalan2, Alison Breland3, Thomas Eissenberg4, David Brown5, Wasim Maziak6.   

Abstract

INTRODUCTION: Flavoured waterpipe (WP) tobacco is a major factor in the resurgence of WP smoking and a main attractant of WP use among youth. Yet, evidence of the effects of limiting flavour on WP smoker's experiences and exposures is limited. This study examined the impact of flavour manipulation on WP smokers' toxicant exposure and smoking experiences.
METHOD: A total of 144 WP smokers attended two, 45 min ad libitum smoking sessions (flavoured vs non-flavoured tobacco) in a crossover design study. Participants completed a battery of questions assessing subjective smoking experiences. Exhaled carbon monoxide (eCO) and plasma nicotine concentrations were measured before and after the smoking sessions. Puff topography was recorded throughout the smoking sessions.
RESULTS: Compared with the non-flavoured WP tobacco, participants reported enhanced subjective smoking measures of satisfaction and enjoyment following smoking flavoured WP tobacco (ps <0.05). Although participants spent a longer time smoking flavoured tobacco, they took on average larger puffs while smoking the non-flavoured tobacco (ps <0.05). Greater levels of eCO were recorded following the non-flavoured tobacco session (p<0.05) compared with flavoured tobacco. No significant differences were observed in plasma nicotine concentrations between the two tobacco conditions. WP harm perception was higher among participants after smoking non-flavoured WP tobacco compared with their preferred flavour (p<0.05).
CONCLUSION: Smoking the flavoured tobacco product was associated with enhanced subjective experiences compared with the non-flavoured, suggesting a potential role for flavour regulation in reducing WP use. Mixed results were observed for toxicants exposure in relation to smoking flavoured compared with non-flavoured products suggesting the need for a more comprehensive assessment of the effects of other tobacco constituents and additives on toxicant exposure in WP smokers. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Addiction; Nicotine; Public policy; Smoking topography

Mesh:

Substances:

Year:  2019        PMID: 31767788      PMCID: PMC7050424          DOI: 10.1136/tobaccocontrol-2019-054972

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  29 in total

1.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings.

Authors:  L S Cox; S T Tiffany; A G Christen
Journal:  Nicotine Tob Res       Date:  2001-02       Impact factor: 4.244

2.  Dissociating nicotine and nonnicotine components of cigarette smoking.

Authors:  J E Rose; F M Behm; E C Westman; M Johnson
Journal:  Pharmacol Biochem Behav       Date:  2000-09       Impact factor: 3.533

3.  Waterpipe tobacco products: nicotine labelling versus nicotine delivery.

Authors:  Andrea R Vansickel; Alan Shihadeh; Thomas Eissenberg
Journal:  Tob Control       Date:  2011-06-02       Impact factor: 7.552

4.  Consensus statement on assessment of waterpipe smoking in epidemiological studies.

Authors:  Wasim Maziak; Ziyad Ben Taleb; Mohammed Jawad; Rima Afifi; Rima Nakkash; Elie A Akl; Kenneth D Ward; Ramzi G Salloum; Tracey E Barnett; Brian A Primack; Scott Sherman; Caroline O Cobb; Erin L Sutfin; Thomas Eissenberg
Journal:  Tob Control       Date:  2016-05-10       Impact factor: 7.552

5.  Flavored Tobacco Product Use in Youth and Adults: Findings From the First Wave of the PATH Study (2013-2014).

Authors:  Andrea C Villanti; Amanda L Johnson; Bridget K Ambrose; K Michael Cummings; Cassandra A Stanton; Shyanika W Rose; Shari P Feirman; Cindy Tworek; Allison M Glasser; Jennifer L Pearson; Amy M Cohn; Kevin P Conway; Raymond S Niaura; Maansi Bansal-Travers; Andrew Hyland
Journal:  Am J Prev Med       Date:  2017-03-16       Impact factor: 5.043

6.  Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2016-05-10

7.  Signs and symptoms of tobacco withdrawal.

Authors:  J R Hughes; D Hatsukami
Journal:  Arch Gen Psychiatry       Date:  1986-03

8.  Comparison of a preferred versus non-preferred waterpipe tobacco flavour: subjective experience, smoking behaviour and toxicant exposure.

Authors:  Eleanor L Leavens; Leslie M Driskill; Neil Molina; Thomas Eissenberg; Alan Shihadeh; Emma I Brett; Evan Floyd; Theodore L Wagener
Journal:  Tob Control       Date:  2017-04-05       Impact factor: 6.953

Review 9.  The global epidemiology of waterpipe smoking.

Authors:  Wasim Maziak; Ziyad Ben Taleb; Raed Bahelah; Farahnaz Islam; Rana Jaber; Rehab Auf; Ramzi G Salloum
Journal:  Tob Control       Date:  2014-10-08       Impact factor: 7.552

10.  Tobacco Product Use Among Middle and High School Students - United States, 2011-2017.

Authors:  Teresa W Wang; Andrea Gentzke; Saida Sharapova; Karen A Cullen; Bridget K Ambrose; Ahmed Jamal
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-06-08       Impact factor: 17.586

View more
  2 in total

1.  Flavored waterpipe tobacco preferences, perceptions, and use in pregnant women: A latent factor mapping approach.

Authors:  Laura R Stroud; George D Papandonatos; Eva Sharma; Nancy C Jao; Samantha Goldman; Chrystal Vergara-Lopez; Lori A J Scott-Sheldon
Journal:  Addict Behav       Date:  2021-11-26       Impact factor: 3.913

2.  The Effect of Graphic Health Warning Labels Placed on the ENDS Device on Young Adult Users' Experience, Exposure and Intention to Use: A Pilot Study.

Authors:  Wei Li; Mayra Vargas-Rivera; Mohammad Ebrahimi Kalan; Ziyad Ben Taleb; Taghrid Asfar; Olatokunbo Osibogun; Seth M Noar; Wasim Maziak
Journal:  Health Commun       Date:  2021-01-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.